Literature DB >> 31651435

Interprofessional Substance Use Disorder Education in Health Professions Education Programs: A Scoping Review.

Andrew Muzyk1, Zachary P W Smothers, Kathryn M Andolsek, Melissa Bradner, Jeffrey P Bratberg, Seth A Clark, Kathryn Collins, Gerard A Greskovic, Larry Gruppen, Mark MacEachern, Susan E Ramsey, Jennifer Ruiz Veve, Jeanette M Tetrault.   

Abstract

PURPOSE: The authors conducted this scoping review to (1) provide a comprehensive evaluation and summation of published literature reporting on interprofessional substance use disorder (SUD) education for students in health professions education programs and (2) appraise the research quality and outcomes of interprofessional SUD education studies. Their goals were to inform health professions educators of interventions that may be useful to consider as they create their own interprofessional SUD courses and to identify areas of improvement for education and research.
METHOD: The authors searched 3 Ovid MEDLINE databases (MEDLINE, In-Process & Other Non-Indexed Citations, and Epub Ahead of Print), Embase.com, ERIC via FirstSearch, and Clarivate Analytics Web of Science from inception through December 7, 2018. The authors used the Medical Education Research Study Quality Instrument (MERSQI) to assess included studies' quality.
RESULTS: The authors screened 1,402 unique articles, and 14 met inclusion criteria. Publications dated from 2014 to 2018. Ten (71%) included students from at least 3 health professions education programs. The mean MERSQI score was 10.64 (SD = 1.73) (range, 7.5-15). Interventions varied by study, and topics included general substance use (n = 4, 29%), tobacco (n = 4, 29%), alcohol (n = 3, 21%), and opioids (n = 3, 21%). Two studies (14%) used a nonrandomized 2-group design. Four (29%) included patients in a clinical setting or panel discussion. Ten (72%) used an assessment tool with validity evidence. Studies reported interventions improved students' educational outcomes related to SUDs and/or interprofessionalism.
CONCLUSIONS: Interprofessional SUD educational interventions improved health professions students' knowledge, skills, and attitudes toward SUDs and interprofessional collaboration. Future SUD curriculum design should emphasize assessment and measure changes in students' behaviors and patient or health care outcomes. Interprofessional SUD education can be instrumental in preparing the future workforce to manage this pressing and complex public health threat.

Entities:  

Mesh:

Year:  2020        PMID: 31651435     DOI: 10.1097/ACM.0000000000003053

Source DB:  PubMed          Journal:  Acad Med        ISSN: 1040-2446            Impact factor:   6.893


  5 in total

Review 1.  Scoping reviews in medical education: A scoping review.

Authors:  Lauren A Maggio; Kelsey Larsen; Aliki Thomas; Joseph A Costello; Anthony R Artino
Journal:  Med Educ       Date:  2020-12-30       Impact factor: 6.251

2.  HealthCare educational differences in pain management, adverse childhood experiences and their relationship to substance use disorder education.

Authors:  Myriam Shaw Ojeda; Aleda M H Chen; Tessa Miracle; Elizabeth Delaney; Caroline E Freiermuth; Jon E Sprague
Journal:  Subst Abuse Treat Prev Policy       Date:  2022-02-07

3.  A Resident-Led Intervention to Increase Initiation of Buprenorphine Maintenance for Hospitalized Patients With Opioid Use Disorder.

Authors:  Ashish P Thakrar; David Furfaro; Sara Keller; Ryan Graddy; Megan Buresh; Leonard Feldman
Journal:  J Hosp Med       Date:  2021-06       Impact factor: 2.899

4.  Medical Student Screening for Naloxone Eligibility in the Emergency Department: A Value-Added Role to Fight the Opioid Epidemic.

Authors:  P Quincy Moore; Navneet Cheema; Sarah Follman; Laura Celmins; Greg Scott; Mai T Pho; Jeanne Farnan; Vineet M Arora; Keme Carter
Journal:  MedEdPORTAL       Date:  2021-12-09

5.  The impact of CARA mandates on nurse practitioner controlled substance prescribing in Oregon: a cohort study.

Authors:  Tracy A Klein; Daniel Hartung; Sheila Markwardt
Journal:  Subst Abuse Treat Prev Policy       Date:  2022-01-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.